
ALT This image shows a comparison of endoscopic views over time. The upper section displays two images labeled as "Index endoscopy," followed by an arrow pointing right to a single image labeled "Diagnostic endoscopy" with a note of "24 months." The lower section has two images with the same labels, with an arrow pointing to "7 months." The images reveal changes in the appearance of tissue in a medical setting.

ALT Sure! Here's a description: "Four-panel medical data chart. Panel A: Pie chart shows diagnoses distribution with categories including Crohn's disease, gastritis, coeliac disease, and others. Panel B: Bar chart with histological correlation to endoscopic impression, divided into abnormal and normal categories. Panel C: Bar chart of laboratory markers diagnosing performance, illustrating sensitivity and specificity for various markers. Panel D: Bar chart of clinical features diagnosing performance, displaying metrics for symptoms like abdominal pain and anemia.

ALT This flowchart outlines the process of a study with sections labeled Enrolment, Allocation, Follow-Up, and Analysis. It shows the number of participants assessed, excluded, and randomized into two groups: Intervention (n=54) and Control (n=51). Details include reasons for participant exclusion and dropout rates throughout the study phases.

ALT Flowchart for managing IBD fatigue. 1. **Fatigue Screening Measures**: Includes IBD-F Self-Assessment Scale and FACIT-Fatigue assessment, categorizing fatigue levels (No fatigue to Severe). 2. **Exclude Other Causes of Fatigue**: Lists diseases, deficiencies, medication side effects, and lifestyle factors. 3. **Patient-led Measures**: Suggests avoiding alcohol, caffeine, and heavy meals. Recommends a balanced diet and regular exercise. 4. **Sleep Difficulties Present?**: - Focus on sleep routine and exercise. - Morning wake time consistency. 5. **Consider Altering Medication**: Guidance on adjusting treatments, checking for partial or effective remission. 6. **Assess Response After 2-3 Months**: Follow-up recommendations, treatment reviews, and measured outcomes. Includes detailed boxes with quantitative scores and criteria within each category.

ALT The image is an informational chart about medications used in treating inflammatory bowel disease (IBD). It is divided into two sections: "Immune Checkpoint Inhibitors (ICI)" and "Targeted therapies." The ICI section includes anti-PD1/PDL-1 medications such as nivolumab and pembrolizumab, and anti-CTLA-4 medication like ipilimumab. The targeted therapies section lists anti-CD20 drugs like rituximab, and BRAF and MEK inhibitors including dabrafenib and trametinib. Each listing describes the medication's effects, common complications, and their association with IBD.





























